Workflow
募集资金管理
icon
Search documents
晋西车轴股份有限公司关于签订募集资金专户存储三方监管协议的公告
Group 1 - The company has signed a tripartite supervision agreement for the storage of raised funds to ensure proper management and protection of investors' rights [2][3] - The company raised a total of RMB 129,000 million through a private placement of shares in August 2013, with a net amount of RMB 126,113.70 million after deducting issuance costs [1] - The company will allocate RMB 2,986 million from the remaining funds of a completed project to a new project focused on the information technology upgrade and efficiency enhancement of high-precision axle production lines [2] Group 2 - A special account for the raised funds has been established at the Bank of Communications, with a current balance of RMB 0 as of September 8, 2025, and the account is exclusively for the new project [3][4] - The agreement stipulates that the sponsor will supervise the use of the raised funds and can conduct on-site inspections and inquiries [4][5] - The company is required to notify the sponsor if withdrawals from the special account exceed 20% of the net amount of raised funds, which is RMB 25,222.74 million [4][5]
深圳市农产品集团股份有限公司第九届董事会第三十次会议决议公告
Group 1 - The company held its 30th meeting of the 9th Board of Directors on September 18, 2025, with all 13 directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][4]. - The Board approved several proposals, including adjustments to the investment amounts for fundraising projects, the use of raised funds to replace self-raised funds for issuance expenses, and the management of idle raised funds [3][5][7]. - The adjustments to the investment amounts for fundraising projects were made to ensure the smooth implementation of these projects without changing the intended use of the funds [23][26]. Group 2 - The Supervisory Board also convened on September 18, 2025, with all 4 supervisors present, and approved similar proposals as the Board of Directors [15][17]. - The company plans to use up to 1.37 billion yuan of temporarily idle raised funds for cash management, ensuring that this does not affect the safety of the funds or the construction of investment projects [41][46]. - The cash management will involve low-risk, high-liquidity investment products, and the company aims to enhance the efficiency of fund usage and increase returns for shareholders [45][51].
仙琚制药及相关人员收浙江证监局警示函 募集资金管理存多项问题
Xin Lang Cai Jing· 2025-09-19 09:34
Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. has received a warning letter from the China Securities Regulatory Commission (CSRC) due to violations in the management and use of raised funds, which included improper procedures and mixing of funds [1][2]. Group 1: Regulatory Findings - The Zhejiang Securities Regulatory Bureau found multiple issues in the management of raised funds, including failure to follow proper review procedures for fund replacement and using raised funds for unrelated expenses [1]. - The company was also found to have mixed raised funds with its own funds when purchasing structured deposit financial products [1]. Group 2: Accountability and Measures - Key executives, including the Chairman, General Manager, CFO, and Board Secretary, were held primarily responsible for the violations and received warning letters [2]. - The company and its executives are required to enhance their understanding of relevant laws and regulations, improve financial management practices, and ensure accurate and timely information disclosure [2]. Group 3: Company Response - The company has expressed its commitment to addressing the issues raised in the warning letter and implementing stricter controls over the use of raised funds [2]. - It emphasized that the regulatory measures will not affect its normal production and operations, and it will continue to fulfill its disclosure obligations [2].
浙江仙琚制药及相关人员因募资问题收到浙江证监局警示函
Xin Lang Cai Jing· 2025-09-19 07:51
Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. has received an administrative regulatory measure decision from the Zhejiang Securities Regulatory Bureau due to issues in fundraising management and usage [1] Group 1: Regulatory Findings - The company was found to have issues such as failure to disclose certain fund replacements as required, payment of unrelated expenses, and mixing of funds [1] - The chairman, Zhang Yusong, along with three other individuals, bear primary responsibility for these issues [1] Group 2: Regulatory Actions - The Zhejiang Securities Regulatory Bureau has decided to issue a warning letter to the company and the related personnel, which will be recorded in their integrity files [1] - The company and the related personnel are required to submit a written report within 10 working days [1] Group 3: Company Response - The company and the related personnel have stated their intention to strengthen regulatory learning and implement corrective measures to prevent recurrence of such issues [1] - The regulatory measures imposed do not affect the normal operations of the company [1]
上海步科自动化股份有限公司关于全资子公司注销部分募集资金专项账户公告
Fundraising Overview - The company Shanghai Buke Automation Co., Ltd. successfully raised a total of RMB 427.14 million by issuing 21 million shares at a price of RMB 20.34 per share, with a net amount of RMB 381.45 million after deducting issuance costs [1] - The funds were fully deposited and verified by Tianjian Accounting Firm, with the verification report issued on November 9, 2020 [1] Fundraising Account Management - The company opened specialized fundraising accounts at various banks, including China Construction Bank and Guangfa Bank, to ensure proper management and usage of the raised funds [2][3] - Multiple tripartite and quadripartite regulatory agreements were signed with the banks and the sponsor, Haitong Securities, to oversee the management of these accounts [3][4] Account Cancellations - Several fundraising accounts have been canceled over the years, including two accounts at China Construction Bank in May 2021 and August 2021, and others at Guangfa Bank and China Construction Bank in subsequent years [5][6][7] - The cancellation of these accounts led to the termination of the associated regulatory agreements [5][6][7] Fund Utilization - The company allocated RMB 120 million of the raised funds to its wholly-owned subsidiary, Shenzhen Buke Electric Co., Ltd., for project implementation, including RMB 46 million for the "Production Center Upgrade Project" [7] - In August 2022, the company approved a change in the investment project from "Production Center Upgrade Project" to "Intelligent Manufacturing Production Base Construction Project," with funds being redirected to another subsidiary, Changzhou Jingna Motor Co., Ltd. [8][9]
深圳市骏鼎达新材料股份有限公司关于设立募集资金专户并签署募集资金监管协议的公告
Core Viewpoint - Shenzhen Jundingda New Materials Co., Ltd. has decided to conclude the "Production Functional Protective Materials East China Headquarters Project" and reallocate the surplus funds of 100.4608 million RMB to invest in the "Jundingda Functional Protective Materials Production Construction Project" to enhance economic efficiency and implement its development strategy [1][2][3]. Fundraising Overview - The company successfully issued 10 million shares at a price of 55.82 RMB per share, raising a total of 558.2 million RMB, with a net amount of 484.0668 million RMB after deducting issuance costs [2][3]. - The raised funds were deposited into a special account on March 15, 2024, and have been verified by Tianjian Accounting Firm [2][3]. Fund Management and Usage - The board of directors approved the conclusion of the previous project and the use of surplus funds for new investments during the meeting on August 15, 2025, which was later ratified by the shareholders on September 5, 2025 [1][2]. - The company has established five fundraising special accounts to manage and store the raised funds, ensuring compliance with relevant laws and regulations [4][3]. Regulatory Agreements - A tripartite supervision agreement was signed on September 18, 2025, between the company, CITIC Bank Guangzhou Branch, and CITIC Securities, detailing the management and usage of the special account [6][7]. - The agreement stipulates that the funds in the special account are exclusively for the designated project and cannot be used for other purposes [5][6]. Monitoring and Compliance - The agreement includes provisions for regular audits and monitoring of the fund usage, with specific thresholds for reporting large withdrawals [8][9]. - The parties involved are required to cooperate in investigations if any irregularities in fund usage are detected [9][10].
尚纬股份有限公司关于募集资金账户注销的公告
Fundraising Overview - The company raised a total of RMB 616 million through a private placement of 104,761,904 shares at a price of RMB 5.88 per share, with a net amount of RMB 605.22 million after deducting related expenses of RMB 10.78 million [2] Fund Management - The company established a fundraising management system to ensure the proper use of raised funds, adhering to principles of regulation, safety, efficiency, and transparency [3] - The company signed a tripartite supervision agreement with banks and its sponsor to manage the special accounts for the raised funds [3] Project Implementation - The company added a new project, "Special Cables for Rail Transit," as a beneficiary of the raised funds and signed a five-party supervision agreement for the management of these funds [4] Fund Account Cancellation - As of October 9, 2024, the company decided to conclude the fundraising investment projects and permanently supplement the remaining funds into working capital, leading to the cancellation of the fundraising special accounts [5] - The balance in the fundraising special accounts was zero at the time of cancellation, and the relevant agreements with banks and sponsors were terminated accordingly [5][6]
四川百利天恒药业股份有限公司关于签署募集资金专户存储监管协议的公告
Fundraising Overview - Sichuan Baili Tianheng Pharmaceutical Co., Ltd. has successfully raised a total of RMB 3,763,999,989.00 by issuing 11,873,817 shares at a price of RMB 317.00 per share, with a net amount of RMB 3,731,054,180.03 after deducting issuance costs [1][2] Fund Management and Regulatory Agreement - The company has established a special account for the management of the raised funds, ensuring that the funds are stored and used specifically for the innovation drug research and development projects [3][4] - A tripartite regulatory agreement has been signed among the company, China Construction Bank Chengdu Eighth Branch, and CITIC Securities, which outlines the management and usage of the raised funds [2][3] Key Provisions of the Agreement - The special account is exclusively for the storage and use of the raised funds, prohibiting any non-raising funds or alternative uses [3] - The company can invest temporarily idle funds in cash management products, provided it complies with relevant regulations and informs the sponsor [3][4] - The sponsor is responsible for ongoing supervision of the fund management and usage, with the authority to conduct investigations and request information from the bank [4][5] Reporting and Compliance - The bank is required to provide monthly account statements to the company and the sponsor, ensuring transparency in fund management [5][6] - Any withdrawals exceeding RMB 50 million or 20% of the net amount must be reported to the sponsor within five working days [5][6] - The agreement remains effective until all funds are fully utilized and the sponsor's supervision period concludes [6]
兆易创新子公司开立募资专户并签四方监管协议
Xin Lang Cai Jing· 2025-09-18 08:50
Core Points - The company, Zhaoyi Innovation (603986), has approved the addition of four wholly-owned subsidiaries as implementation entities for the "Automotive Electronic Chip R&D and Industrialization Project" [1] - The board has agreed to increase capital by 60 million, 60 million, 40 million, and 40 million for the four subsidiaries [1] - As of September 17, the four subsidiaries have opened dedicated fundraising accounts, and a four-party supervision agreement was signed on September 18 with the company, the sponsor CICC, and China Merchants Bank [1] - As of June 30, 2025, the company has utilized a total of 1,950.30 million yuan of the raised funds, leaving a balance of 1,057.53 million yuan [1]
北京映翰通网络技术股份有限公司关于注销部分募集资金专户的公告
Core Points - The company, Beijing Yingtong Network Technology Co., Ltd., has announced the cancellation of certain fundraising accounts as part of its financial management strategy [1][5][6] Fundraising Overview - The company raised a total of RMB 362,151,853.11 through its initial public offering, with a net amount of RMB 313,720,567.80 after deducting various fees [1][2] - The funds were verified by a third-party accounting firm, ensuring compliance with regulatory requirements [2] Fund Management and Usage - The company established a specific management protocol for the use of raised funds, adhering to regulatory guidelines to protect investor interests [3] - A three-party and four-party supervision agreement was signed with the underwriting institution and the bank to ensure strict approval for fund usage [3] Account Cancellation Details - The company has recently completed the cancellation of accounts related to several fundraising projects, including the "Intelligent Low Voltage Distribution Solution R&D Project" [5][6] - The remaining funds from completed projects have been transferred to the company's own accounts for liquidity purposes [5][6]